Study on the Awareness and Willingness of HPV Vaccination Among Women Aged 15 to 45 Based on an Online Survey in Xi’an
DOI:
https://doi.org/10.61173/vqtek068Keywords:
HPV Vaccination, Awareness of HPV Infection, Vaccination WillingnessAbstract
Objective: This study investigates the awareness and willingness of human papillomavirus (HPV) vaccination and its determinants among women aged 15 to 45 years in Xi’an, Shaanxi province. Methods In August 2023, 112 female residents in Xi’an were selected using a convenient sampling method to research their awareness of HPV, health conditions, and vaccination willingness through self-administered network questionnaires. Results: 82.14% of the respondents expressed their willingness to be vaccinated against HPV, 17.86% were reluctant to get HPV vaccination, and 83.1% agreed to include the HPV vaccine in medical insurance. Among those willing to vaccinate, 44 women aged between 15 and 24 account for 39.3%. The age group with the highest awareness score is 25 to 34 years old, with 12.63 as the average awareness score. According to the correlation analysis, awareness of the HPV vaccine was correlated with education (r=0.312, P<0.001). Besides, the vaccination willingness was intertwined with the awareness of the vaccine (r=0.218, P=0.021) and the attitude towards vaccine policy (r=0.392, P<0.001). Conclusion: Women in Xi’an have a high willingness to HPV vaccination, which is related to their awareness of the HPV virus and vaccine-related knowledge as well as policy recognition. It is suggested that the publicity and education of the HPV vaccine should be strengthened in the future, and a reasonable cost-sharing mechanism should be established to improve the overall coverage rate of the HPV vaccine.
References
[1] H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, CA: A Cancer Journal for Clinicians 71(3) (2021) 209-249.
[2] W. Director-General, A world free of cervical cancer, United Nations General Assembly, WHO, 2018.
[3] Global strategy to accelerate the elimination of cervical cancer as a public health problem, Geneva: World Health Organization, 2020.
[4] R.V. Barnabas, E.R. Brown, M.A. Onono, E.A. Bukusi, B. Njoroge, R.L. Winer, D.A. Galloway, L.F. Pinder, D. Donnell, I. Wakhungu, O. Congo, C. Biwott, S. Kimanthi, L. Oluoch, K.B. Heller, H. Leingang, S. Morrison, E. Rechkina, S. Cherne, T.T. Schaafsma, R.S. McClelland, C. Celum, J.M. Baeten, N. Mugo, Efficacy of Single-Dose Human Papillomavirus Vaccination among Young African Women, NEJM Evidence 1(5) (2022) EVIDoa2100056.
[5] V.a.B.d. Immunization, Human papillomavirus vaccines: WHO position paper (2022 update), Weekly epidemiological record, WHO, Weekly epidemiological record, 2022, pp. 645- 672.
[6] Q.R. Dou, C.M. Huang, X. Cao, L.C. Fan. Awareness of human papillomavirus vaccine knowledge and willingness to receive human papillomavirus vaccination among women in Hainan province. Preventive Medicine 35(04) (2023) 359-364.
[7] R. Ran, C.H. Zhang, Y. Huang, J.X. Xu. Willingness to HPV vaccination and its determinants among women in Guangzhou city: an online survey. Chinese Journal of Public Health 37(12) (2021) 1751-1755.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 by the authors.

This work is licensed under a Creative Commons Attribution 4.0 International License.
